New test a ‘major piece’ of the Ebola puzzle

A new
rapid test that can diagnose Ebola in as little as 15 minutes could
play a major role in shutting down the current outbreak. This week, regulators
gave health responders emergency authorization to use the test, which was
codeveloped by Corgenix Medical Corp. based on technology originally discovered
at Tulane University.
Infectious disease specialist Dr. John Schieffelin and
Robert Garry, professor of microbiology and immunology, explain how the test
works and why it’s a potential game-changer.